D-0812-2016 Class III Terminated

Recalled by Jubilant Draximage Inc — Kirkland, N/A

FDA drug recall D-0812-2016 was initiated by Jubilant Draximage Inc on Mar 11, 2016 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength The recall status is terminated (terminated Aug 7, 2017). Affected quantity: 90 vials (450 capsules).

Recall details

Product Type
Drugs
Report Date
Apr 13, 2016
Initiation Date
Mar 11, 2016
Termination Date
Aug 7, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
90 vials (450 capsules)

Product description

SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05

Reason for recall

Labeling: Label Error on Declared Strength

Distribution pattern

Nationwide

Code information

Lot Number 1670123; Exp 04/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0812-2016
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0812-2016. Report a data issue: hello@regdatalab.com.